Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial

Movement Disorders

Volumn 28, Issue 5, 2013, Pages 605-611

  Van der Marck, Marjolein A ^a   Bloem, Bastiaan R ^a   Borm, George F ^a   Overeem, Sebastiaan ^a   Munneke, Marten ^a   Guttman, Mark ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Multidisciplinary care; Parkinson disease; Patient care team; Quality of life; Randomized, controlled trial

Indexed keywords

AGED; ARTICLE; CAREGIVER BURDEN; CLINICAL EFFECTIVENESS; COGNITION; COMMUNICATION SKILL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOTOR DYSFUNCTION; MULTIDISCIPLINARY CARE; NEUROLOGIC EXAMINATION; NEUROLOGIST; NURSE; OUTCOME ASSESSMENT; PAIN; PARKINSON DISEASE; PATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SOCIAL WORKER; STIGMA; UNIFIED PARKINSON DISEASE RATING SCALE;

ACTIVITIES OF DAILY LIVING; AGED; ANALYSIS OF VARIANCE; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84877920475     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25194     Document Type: Article

References (38)

1. Lees AJ, Hardy J, Revesz T.Parkinson's disease. Lancet 2009;373:2055-2066.
2. Chaudhuri KR, Healy DG, Schapira AH.Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
3. Post B, van der EM, Munneke M, Bloem BR.Multidisciplinary care for Parkinson's disease: not if, but how!Pract Neurol 2011;11:58-61.
4. Stewart DA.NICE guideline for Parkinson's disease. Age Ageing 2007;36:240-242.
5. van der Marck MA, Kalf JG, Sturkenboom IH, Nijkrake MJ, Munneke M, Bloem BR.Multidisciplinary care for patients with Parkinson's disease. Parkinsonism Relat Disord 2009;15( Suppl 3):S219-S223.
6. Guo L, Jiang Y, Yatsuya H, Yoshida Y, Sakamoto J.Group education with personal rehabilitation for idiopathic Parkinson's disease. Can J Neurol Sci 2009;36:51-59.
7. Trend P, Kaye J, Gage H, Owen C, Wade D.Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers. Clin Rehabil 2002;16:717-725.
8. Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J.Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2003;74:158-162.
9. Tickle-Degnen L, Ellis T, Saint-Hilaire MH, Thomas CA, Wagenaar RC.Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial. Mov Disord 2010;25:194-204.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ.Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R.The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-248.
12. Peto V, Jenkinson C, Fitzpatrick R.PDQ-39: a review of the development, validation, and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245( Suppl 1):S10-S14.
13. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-207.
14. Peto V, Jenkinson C, Fitzpatrick R.Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 2001;30:299-302.
15. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-591.
16. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ.The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 2010;67:64-70.
17. Hauser RA, Auinger P.Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord 2011;26:813-818.
18. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 2005;65:1436-1441.
19. Jankovic J, Kapadia AS.Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-1615.
20. A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, Le Cessie S, Roos RA.The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. Parkinsonism Relat Disord 2010;16:89-95.
21. Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP.Rate of clinical progression in Parkinson's disease. A prospective study. Mov Disord 2007;22:938-945.
22. Schrag A, Spottke A, Quinn NP, Dodel R.Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord 2009;24:813-818.
23. Ouwens M, Wollersheim H, Hermens R, Hulscher M, Grol R.Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care 2005;17:141-146.
24. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007( 4):CD000197.
25. Langhorne P, Bernhardt J, Kwakkel G.Stroke rehabilitation. Lancet 2011;377:1693-1702.
26. Callahan CM, Boustani MA, Unverzagt FW, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA 2006;295:2148-2157.
27. Meeuwsen EJ, Melis RJF, Van der Aa GCHM, et al. Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ 2012;344:e3086. doi: 10.1136/bmj.33086.
28. Melis RJ, Meeuwsen EJ, Parker SG, Olde Rikkert MG.Are memory clinics effective? The odds are in favour of their benefit, but conclusive evidence is not yet available. J R Soc Med 2009;102:456-457.
29. Nourhashemi F.Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study). BMJ 2010;340:c2466. doi: 10.1136/bmj.c2466.
30. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-696.
31. Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA.Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology 2011;77:851-857.
32. van der Eijk M, Faber MJ, Al SS, Munneke M, Bloem BR.Moving towards patient-centered healthcare for patients with Parkinson's disease. Parkinsonism Relat Disord 2011;17:360-364.
33. Bloem BR, Stocchi F.Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease. Eur J Neurol 2012;19:402-410.
34. Hagell P.Nursing and multidisciplinary interventions for Parkinson's disease: what is the evidence?Parkinsonism Relat Disord 2007;13( Suppl 3):S501-S508.
35. Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR.Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord 2009;24:1-14.
36. Ramig LO, Countryman S, O'Brien C, Hoehn M, Thompson L.Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques. Neurology 1996;47:1496-1504.
37. de Swart BJ, Willemse SC, Maassen BA, Horstink MW.Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology 2003;60:498-500.
38. Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT, Jr. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology 2010;75:2021-2027.